journal
MENU ▼
Read by QxMD icon Read
search

Nature Reviews. Clinical Oncology

journal
https://www.readbyqxmd.com/read/29789701/neoadjuvant-folfirinox-improves-outcomes
#1
Peter Sidaway
No abstract text is available yet for this article.
May 22, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29789700/novel-molecular-classifications-of-dlbcl
#2
Sydney Dubois, Fabrice Jardin
No abstract text is available yet for this article.
May 22, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29789699/genomics-reveals-distinct-gastric-cancer-subtypes
#3
Peter Sidaway
No abstract text is available yet for this article.
May 22, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29784927/ctcs-and-benefit-from-radiotherapy
#4
David Killock
No abstract text is available yet for this article.
May 21, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29784926/clinical-utility-of-circulating-non-coding-rnas-an-update
#5
REVIEW
Simone Anfossi, Anna Babayan, Klaus Pantel, George A Calin
Over the past decade, the amount of research and the number of publications on associations between circulating small and long non-coding RNAs (ncRNAs) and cancer have grown exponentially. Particular focus has been placed on the development of diagnostic and prognostic biomarkers to enable efficient patient management - from early detection of cancer to monitoring for disease recurrence or progression after treatment. Owing to their high abundance and stability, circulating ncRNAs have potential utility as non-invasive, blood-based biomarkers that can provide information on tumour biology and the effects of treatments, such as targeted therapies and immunotherapies...
May 21, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29777163/evolution-of-cll-treatment-from-chemoimmunotherapy-to-targeted-and-individualized-therapy
#6
REVIEW
Jan A Burger, Susan O'Brien
During the past 5 years, a number of highly active novel agents, including kinase inhibitors targeting BTK or PI3Kδ, an antagonist of the antiapoptotic protein BCL-2, and new anti-CD20 monoclonal antibodies, have been added to the therapeutic armamentarium for patients with chronic lymphocytic leukaemia (CLL). In these exciting times, care is needed to optimally integrate these novel agents into the traditional treatment algorithm without overlooking or compromising the benefits of established treatments, especially chemoimmunotherapy...
May 18, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29760506/only-the-best-car-t-cells
#7
Diana Romero
No abstract text is available yet for this article.
May 14, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29760505/low-value-approvals-and-high-prices-might-incentivize-ineffective-drug-development
#8
Vinay Prasad, Christopher McCabe, Sham Mailankody
No abstract text is available yet for this article.
May 14, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29743681/poziotinib-for-uncommon-erbb-mutations
#9
Diana Romero
No abstract text is available yet for this article.
May 9, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29735987/sustainability-and-affordability-of-cancer-drugs-a-novel-pricing-model
#10
Carin A Uyl-de Groot, Bob Löwenberg
No abstract text is available yet for this article.
May 7, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29725041/pembrolizumab-synergizes-with-chemotherapy
#11
Peter Sidaway
No abstract text is available yet for this article.
May 3, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29720713/treatment-resistance-in-urothelial-carcinoma-an-evolutionary-perspective
#12
REVIEW
Panagiotis J Vlachostergios, Bishoy M Faltas
The emergence of treatment-resistant clones is a critical barrier to cure in patients with urothelial carcinoma. Setting the stage for the evolution of resistance, urothelial carcinoma is characterized by extensive mutational heterogeneity, which is detectable even in patients with early stage disease. Chemotherapy and immunotherapy both act as selective pressures that shape the evolutionary trajectory of urothelial carcinoma throughout the course of the disease. A detailed understanding of the dynamics of evolutionary drivers is required for the rational development of curative therapies...
May 2, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29713045/author-correction-analysis-of-dna-methylation-in-cancer-location-revisited
#13
Alexander Koch, Sophie C Joosten, Zheng Feng, Tim C de Ruijter, Muriel X Draht, Veerle Melotte, Kim M Smits, Jurgen Veeck, James G Herman, Leander Van Neste, Wim Van Criekinge, Tim de Meyer, Manon van Engeland
The originally published article contained an error in the acknowledgements section in which the Universiteitsfonds Limburg/SWOL is incorrectly presented as awarding an SU2C- DCS International Translational Cancer Research Dream Team Grant (Stand Up To Cancer (SU2C)-AACR- DT1415, MEDOCC). This has been corrected in the HTML and PDF versions of the manuscript to reflect that Universiteitsfonds Limburg/SWOL is not the funding body that awarded this grant.
April 30, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29703915/nivolumab-ipilimumab-exploiting-the-mutation-burden-of-nsclcs
#14
David Killock
No abstract text is available yet for this article.
April 27, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29700380/tracing-the-steps-of-cancer-evolution
#15
Conor A Bradley
No abstract text is available yet for this article.
April 26, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29700379/neoadjuvant-pd-1-blockade-in-nsclc
#16
David Killock
No abstract text is available yet for this article.
April 26, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29700378/how-to-eliminate-gastric-cancer-related-death-worldwide
#17
Yoshio Yamaoka
No abstract text is available yet for this article.
April 26, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29686422/does-nonmetastatic-castration-resistant-prostate-cancer-still-exist
#18
Celestia S Higano
No abstract text is available yet for this article.
April 23, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29686421/the-multiple-myelomas-current-concepts-in-cytogenetic-classification-and-therapy
#19
REVIEW
Shaji K Kumar, S Vincent Rajkumar
Multiple myeloma (MM) is a plasma cell neoplasm that accounts for 2% of all haematological malignancies and predominantly affects older individuals (with a median age at diagnosis of 65-70 years). MM is consistently preceded by the clinically recognized precancerous stages monoclonal gammopathy of undetermined significance and smouldering MM. Thus far, MM has been considered as a single disease entity, but the clinical presentation, response to treatment, and survival outcomes of patients with MM are quite heterogeneous and highly dependent on a set of chromosomal abnormalities that can be identified in nearly all of them...
April 23, 2018: Nature Reviews. Clinical Oncology
https://www.readbyqxmd.com/read/29674669/the-paradox-of-precision-medicine
#20
Jonathan Kimmelman, Ian Tannock
No abstract text is available yet for this article.
April 19, 2018: Nature Reviews. Clinical Oncology
journal
journal
20200
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"